Spatiotemporal Single-cell Atlas of Peri-implant Soft Tissue Healing
1 other identifier
interventional
5
1 country
1
Brief Summary
This study aims to explore the dynamic changes in different cell types and their molecular regulatory mechanisms during the healing process of peri-implant soft tissues, using single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST). The research will focus specifically on the healing of soft tissues around dental implants in human subjects with the use of a healing abutment. Participants in the healing abutment group will have a micro healing abutment placed immediately after implant placement. Tissue samples will be collected at various time points (Day 4, Day 14, and Day 70) to construct a detailed single-cell map of the healing process. Spatial transcriptomics will be integrated to preserve tissue architecture, enabling the identification of the spatial distribution of different cell types and their interactions within the peri-implant microenvironment. This combined approach will allow for a comprehensive characterization of cellular interactions, spatial gene expression patterns, and regulatory networks specific to healing abutments. The goal is to identify key regulatory factors that could improve peri-implant soft tissue healing and help prevent peri-implantitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 12, 2025
CompletedStudy Start
First participant enrolled
December 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 16, 2025
December 1, 2025
12 months
September 16, 2025
December 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Primary Outcome 1: Differentially Expressed Genes (DEGs) in Peri-implant Soft Tissues
Number of genes significantly differentially expressed between experimental groups, determined by single-cell RNA sequencing (scRNA-seq) analysis (FDR \< 0.05). Unit of Measure: Number of genes.
Day 4, Week 2, Week 4 and Week 8-10 post-implantation.
Cell Type Composition in Peri-implant Soft Tissues
Proportion (%) of each annotated cell type identified by scRNA-seq based on canonical marker expression. Unit of Measure: Percentage of total cells (%)
Day 4, Week 2, Week 4, and Week 8-10 post-implantation.
Enriched Biological Pathways
Number of significantly enriched Gene Ontology (GO) terms and KEGG pathways identified from DEGs (FDR \< 0.05). Unit of Measure: Number of enriched terms/pathways
Day 4, Week 2, Week 4, and Week 8-10 post-implantation
Ligand-Receptor Interaction Strength
Mean interaction score of ligand-receptor pairs identified among annotated cell types using CellPhoneDB (or equivalent computational tool). Unit of Measure: Interaction score (arbitrary units)
Day 4, Week 2, Week 4, and Week 8-10 post-implantation
Spatial Gene Expression Patterns
Localization and expression intensity of selected DEGs across tissue regions determined by the 10x Genomics Visium platform.
Day 4, Week 2, Week 4 and Week 8-10 post-implantation.
Secondary Outcomes (4)
Histological Tissue Morphology
Day 4, Week 2, Week 4 and Week 8-10 post-implantation.
Immune and Stromal Cell Quantification
Day 4, Week 2, Week 4 and Week 8-10 post-implantation.
Junctional Epithelium Length
Day 4, Week 2, Week 4, and Week 8-10 post-implantation.
Basement Membrane Protein Expression
Day 4, Week 2, Week 4, and Week 8-10 post-implantation.
Study Arms (1)
Healing Abutment Gingival Healing Post-Implantation
EXPERIMENTALInterventions
The healing process of peri-implant soft tissues will be studied using a micro healing abutment (2 mm), which will be placed at least three months after implant Stage I surgery. Gingival tissue samples will then be collected at Day 4, Week 2, Week 4, and Week 8-10. At each time point, a circular incision around the micro abutment will be made using a circular punch, and the gingival tissue together with the abutment will be retrieved under local anesthesia. After sampling, the micro abutment will be replaced with a formal healing abutment to maintain healing. Samples will undergo single-cell RNA sequencing (scRNA-seq) to characterize cell types, gene expression changes, and regulatory pathways involved in soft tissue repair. Additional tissues will be used for spatial transcriptomics (ST) and histological staining.
Eligibility Criteria
You may qualify if:
- Age: 18-65 years
- Healthy individuals without chronic medical conditions or severe systemic diseases
- Able to comply with study requirements (e.g., follow-up visits)
- No history of periodontal disease or active infection
- Already completed four or more implant placements in the posterior tooth region
- Adequate gingival thickness to allow for sampling and proper healing
You may not qualify if:
- Individuals with systemic conditions that affect wound healing (e.g., diabetes, immunosuppressive therapy)
- Smoking or alcohol abuse
- Pregnant or breastfeeding women
- History of severe allergic reactions to implant materials
- Participation in another clinical study at the same time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School and Hospital of Stomatology, Fujian Medical University
Fuzhou, Fujian, 350004, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Prosthodontics
Study Record Dates
First Submitted
September 16, 2025
First Posted
December 12, 2025
Study Start
December 20, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 16, 2025
Record last verified: 2025-12